Spinal Tech

Stryker CEO Kevin Lobo and Vice President of Strategy and Investor Relations Katherine Owen discussed the device company's better-than-expected performance for the Mako surgical robotic line and concerns about the spine line going forward during the quarterly investors call.

Lumere named Chicago-based orthopedic surgeon John Cherf, MD, as the company's first CMO.

The global artificial disc market is expected to grow between 2017 and 2023 due to the increasing geriatric population and prevalence of osteoporosis, according to a market report by Precision Business Insights.

Orthofix International received FDA clearance for its Forza XP Expandable Spacer System.

ChoiceSpine made two changes to its leadership team.

Aurora Spine upsized its non-brokered private placement offering of common shares, due to investor demand.

The global wearable medical devices market will likely grow at an 18.3 percent compound annual growth rate, according to a ResearchAndMarkets report.

InVivo Therapeutics named Richard Toselli, MD, permanent CEO and president. He had been serving as acting CEO since Dec. 2017.

Ceterix Orthopaedics completed enrollment in a study of suture-based horizontal meniscal tear repair. The study is the first prospective multicenter investigation of suture-based repair for patients with this common knee injury.

OrthoXel received FDA 510(k) clearance and CE mark approval for their Apex Tibial Nailing System.